According to Lipocine's latest financial reports the company's current EPS (TTM) is -$3.43. In 2022 the company made an earnings per share (EPS) of -$3.15 a decrease over its 2021 EPS that were of -$0.26.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.32 | 5.4% |
2022 | -$3.15 | 1094.12% |
2021 | -$0.26 | -97.5% |
2020 | -$10.56 | -20% |
2019 | -$13.20 | -9.09% |
2018 | -$14.52 | -47.12% |
2017 | -$27.45 | -0% |
2016 | -$27.45 | -4.93% |
2015 | -$28.88 | -31.63% |
2014 | -$42.24 | 74.47% |
2013 | -$24.21 | -99.35% |
2012 | -$3,714 |